BridgeMD
New treatment option for Fractures, Bone
Official title Assessing AI-Supported Fracture Detection in Emergency Care Units
ClinicalTrials.gov ID: NCT06754137
What this study is testing
- What it's testing
- Brief Summary The purpose of this study is to determine if artificial intelligence (AI) can assist doctors in detecting broken bones, effusions, dislocations and bone lesions more quickly and accurately in an emergency room setting. The study will also evaluate whether AI can save time and reduce costs in healthcare.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Presenting to the emergency department with an isolated injury or joint complaint
- Patients able and willing to provide informed consent.
You likely can't join if
- Patients with injuries or complaints involving multiple body regions
- Patients with prior imaging of the affected extremity or region within the past 6 months
- Contraindications to X-ray imaging (e.g., pregnancy or severe instability)
- Patients with other ongoing studies that may interfere with this study
- Patients unable to provide consent due to cognitive impairment or language barriers without an available representative.
The study team makes the final eligibility decision.
Where it's taking place
- Hallein, Austria
- Salzburg, Austria
- Nuremberg, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hallein, Austria; Salzburg, Austria; Nuremberg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.